Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer

Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer

Lukas Löfling, Anders Sundström, Helle Kieler, Shahram Bahmanyar, Marie Linder Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institute, Solna, Sweden Introduction: One out of six adults has symptoms of overactive bladder (OAB). Antimuscarinic medication is the...

Full description

Bibliographic Details
Main Authors: Löfling L, Sundström A, Kieler H, Bahmanyar S, Linder M
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:Clinical Epidemiology
Subjects:
Overactive bladder
antimuscarinic medications
lung cancer
colon cancer
Online Access:https://www.dovepress.com/exposure-to-antimuscarinic-medications-for-treatment-of-overactive-bla-peer-reviewed-article-CLEP

Internet

https://www.dovepress.com/exposure-to-antimuscarinic-medications-for-treatment-of-overactive-bla-peer-reviewed-article-CLEP

Similar Items